Clinical heterogeneity and treatment response in inclusion body myositis

Miriam Richter Cohen, A. R. Sulaiman, John C. Garancis, Robert L. Wortmann

Research output: Contribution to journalArticle

Abstract

Inclusion body myositis has been described as an inflammatory myopathy with distinctive clinical and pathologic features that is refractory to treatment. Ten cases of inclusion body myositis, as defined by histopathologic findings, were reviewed to determine whether the clinical characteristics are different in patients whose disease has been defined by light and electron microscopic studies compared with those whose disease has been defined by light microscopic studies alone. The clinical characteristics of both groups of patients were similar, and 2 patients have had excellent responses to treatment. Although inclusion body myositis represents a histologic subset of polymyositis, from a clinical perspective, it must be considered a nonspecific designation. Despite a generally poor prognosis, therapeutic intervention is still warranted.

Original languageEnglish (US)
Pages (from-to)734-740
Number of pages7
JournalArthritis & Rheumatism
Volume32
Issue number6
DOIs
StatePublished - Jun 1989

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Clinical heterogeneity and treatment response in inclusion body myositis'. Together they form a unique fingerprint.

  • Cite this

    Cohen, M. R., Sulaiman, A. R., Garancis, J. C., & Wortmann, R. L. (1989). Clinical heterogeneity and treatment response in inclusion body myositis. Arthritis & Rheumatism, 32(6), 734-740. https://doi.org/10.1002/anr.1780320611